nodes	percent_of_prediction	percent_of_DWPC	metapath
Frovatriptan—CYP1A2—Carbamazepine—epilepsy syndrome	0.0587	0.203	CbGbCtD
Frovatriptan—CYP1A2—Primidone—epilepsy syndrome	0.0548	0.19	CbGbCtD
Frovatriptan—CYP1A2—Propofol—epilepsy syndrome	0.0491	0.17	CbGbCtD
Frovatriptan—CYP1A2—Phenobarbital—epilepsy syndrome	0.0469	0.162	CbGbCtD
Frovatriptan—CYP1A2—Diazepam—epilepsy syndrome	0.0445	0.154	CbGbCtD
Frovatriptan—CYP1A2—Valproic Acid—epilepsy syndrome	0.0351	0.121	CbGbCtD
Frovatriptan—HTR1D—meninx—epilepsy syndrome	0.0336	0.31	CbGeAlD
Frovatriptan—HTR1B—telencephalic ventricle—epilepsy syndrome	0.00795	0.0734	CbGeAlD
Frovatriptan—HTR1D—telencephalic ventricle—epilepsy syndrome	0.0077	0.071	CbGeAlD
Frovatriptan—HTR1A—telencephalic ventricle—epilepsy syndrome	0.00642	0.0592	CbGeAlD
Frovatriptan—HTR1B—ganglion—epilepsy syndrome	0.00495	0.0457	CbGeAlD
Frovatriptan—HTR1D—ganglion—epilepsy syndrome	0.00479	0.0442	CbGeAlD
Frovatriptan—HTR1A—ganglion—epilepsy syndrome	0.00399	0.0369	CbGeAlD
Frovatriptan—HTR1A—hindbrain—epilepsy syndrome	0.00303	0.028	CbGeAlD
Frovatriptan—HTR1B—brainstem—epilepsy syndrome	0.00215	0.0199	CbGeAlD
Frovatriptan—HTR1D—brainstem—epilepsy syndrome	0.00208	0.0192	CbGeAlD
Frovatriptan—HTR1B—forebrain—epilepsy syndrome	0.00208	0.0192	CbGeAlD
Frovatriptan—HTR1D—forebrain—epilepsy syndrome	0.00201	0.0186	CbGeAlD
Frovatriptan—HTR1B—telencephalon—epilepsy syndrome	0.00191	0.0176	CbGeAlD
Frovatriptan—HTR1D—telencephalon—epilepsy syndrome	0.00185	0.0171	CbGeAlD
Frovatriptan—HTR1A—brainstem—epilepsy syndrome	0.00174	0.016	CbGeAlD
Frovatriptan—HTR1A—forebrain—epilepsy syndrome	0.00168	0.0155	CbGeAlD
Frovatriptan—HTR1A—telencephalon—epilepsy syndrome	0.00154	0.0142	CbGeAlD
Frovatriptan—HTR1B—midbrain—epilepsy syndrome	0.00137	0.0127	CbGeAlD
Frovatriptan—HTR1B—spinal cord—epilepsy syndrome	0.00134	0.0123	CbGeAlD
Frovatriptan—HTR1D—midbrain—epilepsy syndrome	0.00133	0.0123	CbGeAlD
Frovatriptan—HTR1B—head—epilepsy syndrome	0.00119	0.011	CbGeAlD
Frovatriptan—HTR1D—head—epilepsy syndrome	0.00115	0.0106	CbGeAlD
Frovatriptan—HTR1B—nervous system—epilepsy syndrome	0.00113	0.0104	CbGeAlD
Frovatriptan—HTR1A—midbrain—epilepsy syndrome	0.00111	0.0102	CbGeAlD
Frovatriptan—HTR1D—nervous system—epilepsy syndrome	0.00109	0.0101	CbGeAlD
Frovatriptan—HTR1B—central nervous system—epilepsy syndrome	0.00109	0.01	CbGeAlD
Frovatriptan—HTR1A—spinal cord—epilepsy syndrome	0.00108	0.00996	CbGeAlD
Frovatriptan—HTR1D—central nervous system—epilepsy syndrome	0.00105	0.0097	CbGeAlD
Frovatriptan—HTR1A—head—epilepsy syndrome	0.000959	0.00885	CbGeAlD
Frovatriptan—HTR1A—nervous system—epilepsy syndrome	0.00091	0.00839	CbGeAlD
Frovatriptan—HTR1A—central nervous system—epilepsy syndrome	0.000876	0.00808	CbGeAlD
Frovatriptan—HTR1B—brain—epilepsy syndrome	0.000862	0.00795	CbGeAlD
Frovatriptan—HTR1A—cerebellum—epilepsy syndrome	0.000856	0.0079	CbGeAlD
Frovatriptan—HTR1D—brain—epilepsy syndrome	0.000834	0.0077	CbGeAlD
Frovatriptan—HTR1A—brain—epilepsy syndrome	0.000695	0.00642	CbGeAlD
Frovatriptan—Asthenia—Zonisamide—epilepsy syndrome	0.000114	0.000253	CcSEcCtD
Frovatriptan—Mental disorder—Gabapentin—epilepsy syndrome	0.000114	0.000253	CcSEcCtD
Frovatriptan—Dry mouth—Valproic Acid—epilepsy syndrome	0.000114	0.000252	CcSEcCtD
Frovatriptan—Agitation—Pregabalin—epilepsy syndrome	0.000113	0.000251	CcSEcCtD
Frovatriptan—Headache—Levetiracetam—epilepsy syndrome	0.000113	0.000251	CcSEcCtD
Frovatriptan—Malnutrition—Gabapentin—epilepsy syndrome	0.000113	0.000251	CcSEcCtD
Frovatriptan—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000113	0.00025	CcSEcCtD
Frovatriptan—Dizziness—Vigabatrin—epilepsy syndrome	0.000113	0.00025	CcSEcCtD
Frovatriptan—Confusional state—Valproic Acid—epilepsy syndrome	0.000112	0.000249	CcSEcCtD
Frovatriptan—Pruritus—Zonisamide—epilepsy syndrome	0.000112	0.000249	CcSEcCtD
Frovatriptan—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000112	0.000248	CcSEcCtD
Frovatriptan—Flatulence—Gabapentin—epilepsy syndrome	0.000111	0.000247	CcSEcCtD
Frovatriptan—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.000111	0.000247	CcSEcCtD
Frovatriptan—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000111	0.000247	CcSEcCtD
Frovatriptan—Bradycardia—Topiramate—epilepsy syndrome	0.000111	0.000247	CcSEcCtD
Frovatriptan—Malaise—Pregabalin—epilepsy syndrome	0.000111	0.000247	CcSEcCtD
Frovatriptan—Nausea—Propofol—epilepsy syndrome	0.000111	0.000247	CcSEcCtD
Frovatriptan—Tension—Gabapentin—epilepsy syndrome	0.000111	0.000246	CcSEcCtD
Frovatriptan—Vomiting—Fosphenytoin—epilepsy syndrome	0.000111	0.000246	CcSEcCtD
Frovatriptan—Diarrhoea—Felbamate—epilepsy syndrome	0.000111	0.000246	CcSEcCtD
Frovatriptan—Vertigo—Pregabalin—epilepsy syndrome	0.000111	0.000246	CcSEcCtD
Frovatriptan—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000111	0.000246	CcSEcCtD
Frovatriptan—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000111	0.000246	CcSEcCtD
Frovatriptan—Dysgeusia—Gabapentin—epilepsy syndrome	0.000111	0.000246	CcSEcCtD
Frovatriptan—Dizziness—Diazepam—epilepsy syndrome	0.000111	0.000246	CcSEcCtD
Frovatriptan—Syncope—Pregabalin—epilepsy syndrome	0.000111	0.000245	CcSEcCtD
Frovatriptan—Haemoglobin—Topiramate—epilepsy syndrome	0.00011	0.000244	CcSEcCtD
Frovatriptan—Nervousness—Gabapentin—epilepsy syndrome	0.00011	0.000244	CcSEcCtD
Frovatriptan—Asthenia—Clonazepam—epilepsy syndrome	0.00011	0.000243	CcSEcCtD
Frovatriptan—Rhinitis—Topiramate—epilepsy syndrome	0.00011	0.000243	CcSEcCtD
Frovatriptan—Back pain—Gabapentin—epilepsy syndrome	0.000109	0.000243	CcSEcCtD
Frovatriptan—Headache—Fosphenytoin—epilepsy syndrome	0.000109	0.000243	CcSEcCtD
Frovatriptan—Haemorrhage—Topiramate—epilepsy syndrome	0.000109	0.000243	CcSEcCtD
Frovatriptan—Palpitations—Pregabalin—epilepsy syndrome	0.000109	0.000242	CcSEcCtD
Frovatriptan—Asthenia—Phenytoin—epilepsy syndrome	0.000109	0.000242	CcSEcCtD
Frovatriptan—Nausea—Midazolam—epilepsy syndrome	0.000109	0.000241	CcSEcCtD
Frovatriptan—Hypoaesthesia—Topiramate—epilepsy syndrome	0.000109	0.000241	CcSEcCtD
Frovatriptan—Muscle spasms—Gabapentin—epilepsy syndrome	0.000109	0.000241	CcSEcCtD
Frovatriptan—Tachycardia—Valproic Acid—epilepsy syndrome	0.000109	0.000241	CcSEcCtD
Frovatriptan—Diarrhoea—Zonisamide—epilepsy syndrome	0.000109	0.000241	CcSEcCtD
Frovatriptan—Pharyngitis—Topiramate—epilepsy syndrome	0.000108	0.000241	CcSEcCtD
Frovatriptan—Loss of consciousness—Pregabalin—epilepsy syndrome	0.000108	0.000241	CcSEcCtD
Frovatriptan—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000108	0.000241	CcSEcCtD
Frovatriptan—Pruritus—Clonazepam—epilepsy syndrome	0.000108	0.00024	CcSEcCtD
Frovatriptan—Vomiting—Vigabatrin—epilepsy syndrome	0.000108	0.00024	CcSEcCtD
Frovatriptan—Urinary tract disorder—Topiramate—epilepsy syndrome	0.000108	0.000239	CcSEcCtD
Frovatriptan—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.000108	0.000239	CcSEcCtD
Frovatriptan—Pruritus—Phenytoin—epilepsy syndrome	0.000107	0.000238	CcSEcCtD
Frovatriptan—Nausea—Levetiracetam—epilepsy syndrome	0.000107	0.000238	CcSEcCtD
Frovatriptan—Dizziness—Felbamate—epilepsy syndrome	0.000107	0.000238	CcSEcCtD
Frovatriptan—Urethral disorder—Topiramate—epilepsy syndrome	0.000107	0.000238	CcSEcCtD
Frovatriptan—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000107	0.000237	CcSEcCtD
Frovatriptan—Convulsion—Pregabalin—epilepsy syndrome	0.000107	0.000237	CcSEcCtD
Frovatriptan—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000107	0.000237	CcSEcCtD
Frovatriptan—Headache—Vigabatrin—epilepsy syndrome	0.000107	0.000236	CcSEcCtD
Frovatriptan—Vomiting—Diazepam—epilepsy syndrome	0.000106	0.000236	CcSEcCtD
Frovatriptan—Anorexia—Valproic Acid—epilepsy syndrome	0.000106	0.000235	CcSEcCtD
Frovatriptan—Tremor—Gabapentin—epilepsy syndrome	0.000106	0.000235	CcSEcCtD
Frovatriptan—Visual impairment—Topiramate—epilepsy syndrome	0.000105	0.000234	CcSEcCtD
Frovatriptan—Myalgia—Pregabalin—epilepsy syndrome	0.000105	0.000233	CcSEcCtD
Frovatriptan—Chest pain—Pregabalin—epilepsy syndrome	0.000105	0.000233	CcSEcCtD
Frovatriptan—Arthralgia—Pregabalin—epilepsy syndrome	0.000105	0.000233	CcSEcCtD
Frovatriptan—Ill-defined disorder—Gabapentin—epilepsy syndrome	0.000105	0.000233	CcSEcCtD
Frovatriptan—Dizziness—Zonisamide—epilepsy syndrome	0.000105	0.000233	CcSEcCtD
Frovatriptan—Headache—Diazepam—epilepsy syndrome	0.000105	0.000233	CcSEcCtD
Frovatriptan—Anxiety—Pregabalin—epilepsy syndrome	0.000105	0.000232	CcSEcCtD
Frovatriptan—Diarrhoea—Clonazepam—epilepsy syndrome	0.000105	0.000232	CcSEcCtD
Frovatriptan—Asthenia—Carbamazepine—epilepsy syndrome	0.000104	0.000231	CcSEcCtD
Frovatriptan—Agitation—Gabapentin—epilepsy syndrome	0.000104	0.000231	CcSEcCtD
Frovatriptan—Diarrhoea—Phenytoin—epilepsy syndrome	0.000104	0.000231	CcSEcCtD
Frovatriptan—Discomfort—Pregabalin—epilepsy syndrome	0.000104	0.00023	CcSEcCtD
Frovatriptan—Nausea—Fosphenytoin—epilepsy syndrome	0.000104	0.00023	CcSEcCtD
Frovatriptan—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000103	0.000229	CcSEcCtD
Frovatriptan—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000103	0.000229	CcSEcCtD
Frovatriptan—Vomiting—Felbamate—epilepsy syndrome	0.000103	0.000229	CcSEcCtD
Frovatriptan—Dry mouth—Pregabalin—epilepsy syndrome	0.000103	0.000228	CcSEcCtD
Frovatriptan—Pruritus—Carbamazepine—epilepsy syndrome	0.000103	0.000228	CcSEcCtD
Frovatriptan—Malaise—Gabapentin—epilepsy syndrome	0.000102	0.000226	CcSEcCtD
Frovatriptan—Tinnitus—Topiramate—epilepsy syndrome	0.000102	0.000226	CcSEcCtD
Frovatriptan—Vertigo—Gabapentin—epilepsy syndrome	0.000102	0.000225	CcSEcCtD
Frovatriptan—Headache—Felbamate—epilepsy syndrome	0.000102	0.000225	CcSEcCtD
Frovatriptan—Confusional state—Pregabalin—epilepsy syndrome	0.000102	0.000225	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000101	0.000225	CcSEcCtD
Frovatriptan—Flushing—Topiramate—epilepsy syndrome	0.000101	0.000225	CcSEcCtD
Frovatriptan—Syncope—Gabapentin—epilepsy syndrome	0.000101	0.000225	CcSEcCtD
Frovatriptan—Dizziness—Clonazepam—epilepsy syndrome	0.000101	0.000224	CcSEcCtD
Frovatriptan—Nausea—Vigabatrin—epilepsy syndrome	0.000101	0.000224	CcSEcCtD
Frovatriptan—Vomiting—Zonisamide—epilepsy syndrome	0.000101	0.000224	CcSEcCtD
Frovatriptan—Insomnia—Valproic Acid—epilepsy syndrome	0.000101	0.000223	CcSEcCtD
Frovatriptan—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000101	0.000223	CcSEcCtD
Frovatriptan—Asthenia—Lamotrigine—epilepsy syndrome	0.000101	0.000223	CcSEcCtD
Frovatriptan—Dizziness—Phenytoin—epilepsy syndrome	0.0001	0.000223	CcSEcCtD
Frovatriptan—Paraesthesia—Valproic Acid—epilepsy syndrome	0.0001	0.000222	CcSEcCtD
Frovatriptan—Palpitations—Gabapentin—epilepsy syndrome	0.0001	0.000222	CcSEcCtD
Frovatriptan—Dizziness—Oxcarbazepine—epilepsy syndrome	9.99e-05	0.000222	CcSEcCtD
Frovatriptan—Nausea—Diazepam—epilepsy syndrome	9.95e-05	0.000221	CcSEcCtD
Frovatriptan—Loss of consciousness—Gabapentin—epilepsy syndrome	9.94e-05	0.000221	CcSEcCtD
Frovatriptan—Headache—Zonisamide—epilepsy syndrome	9.94e-05	0.000221	CcSEcCtD
Frovatriptan—Dyspnoea—Valproic Acid—epilepsy syndrome	9.93e-05	0.00022	CcSEcCtD
Frovatriptan—Diarrhoea—Carbamazepine—epilepsy syndrome	9.92e-05	0.00022	CcSEcCtD
Frovatriptan—Pruritus—Lamotrigine—epilepsy syndrome	9.91e-05	0.00022	CcSEcCtD
Frovatriptan—Shock—Pregabalin—epilepsy syndrome	9.9e-05	0.00022	CcSEcCtD
Frovatriptan—Somnolence—Valproic Acid—epilepsy syndrome	9.9e-05	0.00022	CcSEcCtD
Frovatriptan—Tachycardia—Pregabalin—epilepsy syndrome	9.83e-05	0.000218	CcSEcCtD
Frovatriptan—Chills—Topiramate—epilepsy syndrome	9.81e-05	0.000218	CcSEcCtD
Frovatriptan—Dyspepsia—Valproic Acid—epilepsy syndrome	9.8e-05	0.000217	CcSEcCtD
Frovatriptan—Convulsion—Gabapentin—epilepsy syndrome	9.8e-05	0.000217	CcSEcCtD
Frovatriptan—Hyperhidrosis—Pregabalin—epilepsy syndrome	9.73e-05	0.000216	CcSEcCtD
Frovatriptan—Vomiting—Clonazepam—epilepsy syndrome	9.72e-05	0.000216	CcSEcCtD
Frovatriptan—Decreased appetite—Valproic Acid—epilepsy syndrome	9.68e-05	0.000215	CcSEcCtD
Frovatriptan—Vomiting—Phenytoin—epilepsy syndrome	9.66e-05	0.000214	CcSEcCtD
Frovatriptan—Arthralgia—Gabapentin—epilepsy syndrome	9.63e-05	0.000214	CcSEcCtD
Frovatriptan—Chest pain—Gabapentin—epilepsy syndrome	9.63e-05	0.000214	CcSEcCtD
Frovatriptan—Myalgia—Gabapentin—epilepsy syndrome	9.63e-05	0.000214	CcSEcCtD
Frovatriptan—Nausea—Felbamate—epilepsy syndrome	9.63e-05	0.000214	CcSEcCtD
Frovatriptan—Vomiting—Oxcarbazepine—epilepsy syndrome	9.61e-05	0.000213	CcSEcCtD
Frovatriptan—Fatigue—Valproic Acid—epilepsy syndrome	9.6e-05	0.000213	CcSEcCtD
Frovatriptan—Anxiety—Gabapentin—epilepsy syndrome	9.6e-05	0.000213	CcSEcCtD
Frovatriptan—Anorexia—Pregabalin—epilepsy syndrome	9.6e-05	0.000213	CcSEcCtD
Frovatriptan—Dizziness—Carbamazepine—epilepsy syndrome	9.59e-05	0.000213	CcSEcCtD
Frovatriptan—Diarrhoea—Lamotrigine—epilepsy syndrome	9.59e-05	0.000213	CcSEcCtD
Frovatriptan—Headache—Clonazepam—epilepsy syndrome	9.58e-05	0.000213	CcSEcCtD
Frovatriptan—Mental disorder—Topiramate—epilepsy syndrome	9.58e-05	0.000212	CcSEcCtD
Frovatriptan—Constipation—Valproic Acid—epilepsy syndrome	9.52e-05	0.000211	CcSEcCtD
Frovatriptan—Pain—Valproic Acid—epilepsy syndrome	9.52e-05	0.000211	CcSEcCtD
Frovatriptan—Headache—Phenytoin—epilepsy syndrome	9.52e-05	0.000211	CcSEcCtD
Frovatriptan—Malnutrition—Topiramate—epilepsy syndrome	9.52e-05	0.000211	CcSEcCtD
Frovatriptan—Discomfort—Gabapentin—epilepsy syndrome	9.51e-05	0.000211	CcSEcCtD
Frovatriptan—Headache—Oxcarbazepine—epilepsy syndrome	9.47e-05	0.00021	CcSEcCtD
Frovatriptan—Nausea—Zonisamide—epilepsy syndrome	9.43e-05	0.000209	CcSEcCtD
Frovatriptan—Dry mouth—Gabapentin—epilepsy syndrome	9.42e-05	0.000209	CcSEcCtD
Frovatriptan—Flatulence—Topiramate—epilepsy syndrome	9.38e-05	0.000208	CcSEcCtD
Frovatriptan—Tension—Topiramate—epilepsy syndrome	9.34e-05	0.000207	CcSEcCtD
Frovatriptan—Dysgeusia—Topiramate—epilepsy syndrome	9.32e-05	0.000207	CcSEcCtD
Frovatriptan—Confusional state—Gabapentin—epilepsy syndrome	9.31e-05	0.000206	CcSEcCtD
Frovatriptan—Dizziness—Lamotrigine—epilepsy syndrome	9.27e-05	0.000206	CcSEcCtD
Frovatriptan—Nervousness—Topiramate—epilepsy syndrome	9.24e-05	0.000205	CcSEcCtD
Frovatriptan—Anaphylactic shock—Gabapentin—epilepsy syndrome	9.23e-05	0.000205	CcSEcCtD
Frovatriptan—Vomiting—Carbamazepine—epilepsy syndrome	9.22e-05	0.000205	CcSEcCtD
Frovatriptan—Back pain—Topiramate—epilepsy syndrome	9.21e-05	0.000204	CcSEcCtD
Frovatriptan—Feeling abnormal—Valproic Acid—epilepsy syndrome	9.18e-05	0.000204	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	9.17e-05	0.000203	CcSEcCtD
Frovatriptan—Muscle spasms—Topiramate—epilepsy syndrome	9.15e-05	0.000203	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	9.11e-05	0.000202	CcSEcCtD
Frovatriptan—Insomnia—Pregabalin—epilepsy syndrome	9.11e-05	0.000202	CcSEcCtD
Frovatriptan—Nausea—Clonazepam—epilepsy syndrome	9.08e-05	0.000202	CcSEcCtD
Frovatriptan—Headache—Carbamazepine—epilepsy syndrome	9.08e-05	0.000202	CcSEcCtD
Frovatriptan—Shock—Gabapentin—epilepsy syndrome	9.08e-05	0.000201	CcSEcCtD
Frovatriptan—Paraesthesia—Pregabalin—epilepsy syndrome	9.04e-05	0.000201	CcSEcCtD
Frovatriptan—Nausea—Phenytoin—epilepsy syndrome	9.02e-05	0.0002	CcSEcCtD
Frovatriptan—Tachycardia—Gabapentin—epilepsy syndrome	9.01e-05	0.0002	CcSEcCtD
Frovatriptan—Dyspnoea—Pregabalin—epilepsy syndrome	8.98e-05	0.000199	CcSEcCtD
Frovatriptan—Nausea—Oxcarbazepine—epilepsy syndrome	8.98e-05	0.000199	CcSEcCtD
Frovatriptan—Somnolence—Pregabalin—epilepsy syndrome	8.95e-05	0.000199	CcSEcCtD
Frovatriptan—Hyperhidrosis—Gabapentin—epilepsy syndrome	8.92e-05	0.000198	CcSEcCtD
Frovatriptan—Tremor—Topiramate—epilepsy syndrome	8.92e-05	0.000198	CcSEcCtD
Frovatriptan—Vomiting—Lamotrigine—epilepsy syndrome	8.91e-05	0.000198	CcSEcCtD
Frovatriptan—Ill-defined disorder—Topiramate—epilepsy syndrome	8.83e-05	0.000196	CcSEcCtD
Frovatriptan—Abdominal pain—Valproic Acid—epilepsy syndrome	8.8e-05	0.000195	CcSEcCtD
Frovatriptan—Body temperature increased—Valproic Acid—epilepsy syndrome	8.8e-05	0.000195	CcSEcCtD
Frovatriptan—Anorexia—Gabapentin—epilepsy syndrome	8.8e-05	0.000195	CcSEcCtD
Frovatriptan—Headache—Lamotrigine—epilepsy syndrome	8.78e-05	0.000195	CcSEcCtD
Frovatriptan—Decreased appetite—Pregabalin—epilepsy syndrome	8.75e-05	0.000194	CcSEcCtD
Frovatriptan—Agitation—Topiramate—epilepsy syndrome	8.75e-05	0.000194	CcSEcCtD
Frovatriptan—Fatigue—Pregabalin—epilepsy syndrome	8.68e-05	0.000193	CcSEcCtD
Frovatriptan—Nausea—Carbamazepine—epilepsy syndrome	8.61e-05	0.000191	CcSEcCtD
Frovatriptan—Pain—Pregabalin—epilepsy syndrome	8.61e-05	0.000191	CcSEcCtD
Frovatriptan—Constipation—Pregabalin—epilepsy syndrome	8.61e-05	0.000191	CcSEcCtD
Frovatriptan—Malaise—Topiramate—epilepsy syndrome	8.58e-05	0.00019	CcSEcCtD
Frovatriptan—Vertigo—Topiramate—epilepsy syndrome	8.55e-05	0.00019	CcSEcCtD
Frovatriptan—Syncope—Topiramate—epilepsy syndrome	8.53e-05	0.000189	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	8.41e-05	0.000187	CcSEcCtD
Frovatriptan—Palpitations—Topiramate—epilepsy syndrome	8.41e-05	0.000187	CcSEcCtD
Frovatriptan—Loss of consciousness—Topiramate—epilepsy syndrome	8.36e-05	0.000186	CcSEcCtD
Frovatriptan—Insomnia—Gabapentin—epilepsy syndrome	8.35e-05	0.000185	CcSEcCtD
Frovatriptan—Nausea—Lamotrigine—epilepsy syndrome	8.32e-05	0.000185	CcSEcCtD
Frovatriptan—Feeling abnormal—Pregabalin—epilepsy syndrome	8.3e-05	0.000184	CcSEcCtD
Frovatriptan—Paraesthesia—Gabapentin—epilepsy syndrome	8.29e-05	0.000184	CcSEcCtD
Frovatriptan—Convulsion—Topiramate—epilepsy syndrome	8.25e-05	0.000183	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Pregabalin—epilepsy syndrome	8.23e-05	0.000183	CcSEcCtD
Frovatriptan—Dyspnoea—Gabapentin—epilepsy syndrome	8.23e-05	0.000183	CcSEcCtD
Frovatriptan—Somnolence—Gabapentin—epilepsy syndrome	8.21e-05	0.000182	CcSEcCtD
Frovatriptan—Hypersensitivity—Valproic Acid—epilepsy syndrome	8.2e-05	0.000182	CcSEcCtD
Frovatriptan—Dyspepsia—Gabapentin—epilepsy syndrome	8.13e-05	0.00018	CcSEcCtD
Frovatriptan—Myalgia—Topiramate—epilepsy syndrome	8.1e-05	0.00018	CcSEcCtD
Frovatriptan—Arthralgia—Topiramate—epilepsy syndrome	8.1e-05	0.00018	CcSEcCtD
Frovatriptan—Chest pain—Topiramate—epilepsy syndrome	8.1e-05	0.00018	CcSEcCtD
Frovatriptan—Anxiety—Topiramate—epilepsy syndrome	8.07e-05	0.000179	CcSEcCtD
Frovatriptan—Decreased appetite—Gabapentin—epilepsy syndrome	8.02e-05	0.000178	CcSEcCtD
Frovatriptan—Discomfort—Topiramate—epilepsy syndrome	8e-05	0.000178	CcSEcCtD
Frovatriptan—Asthenia—Valproic Acid—epilepsy syndrome	7.99e-05	0.000177	CcSEcCtD
Frovatriptan—Fatigue—Gabapentin—epilepsy syndrome	7.96e-05	0.000177	CcSEcCtD
Frovatriptan—Abdominal pain—Pregabalin—epilepsy syndrome	7.96e-05	0.000177	CcSEcCtD
Frovatriptan—Body temperature increased—Pregabalin—epilepsy syndrome	7.96e-05	0.000177	CcSEcCtD
Frovatriptan—Dry mouth—Topiramate—epilepsy syndrome	7.92e-05	0.000176	CcSEcCtD
Frovatriptan—Constipation—Gabapentin—epilepsy syndrome	7.89e-05	0.000175	CcSEcCtD
Frovatriptan—Pain—Gabapentin—epilepsy syndrome	7.89e-05	0.000175	CcSEcCtD
Frovatriptan—Pruritus—Valproic Acid—epilepsy syndrome	7.88e-05	0.000175	CcSEcCtD
Frovatriptan—Confusional state—Topiramate—epilepsy syndrome	7.83e-05	0.000174	CcSEcCtD
Frovatriptan—Shock—Topiramate—epilepsy syndrome	7.64e-05	0.00017	CcSEcCtD
Frovatriptan—Diarrhoea—Valproic Acid—epilepsy syndrome	7.62e-05	0.000169	CcSEcCtD
Frovatriptan—Feeling abnormal—Gabapentin—epilepsy syndrome	7.61e-05	0.000169	CcSEcCtD
Frovatriptan—Tachycardia—Topiramate—epilepsy syndrome	7.58e-05	0.000168	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Gabapentin—epilepsy syndrome	7.55e-05	0.000167	CcSEcCtD
Frovatriptan—Hyperhidrosis—Topiramate—epilepsy syndrome	7.51e-05	0.000167	CcSEcCtD
Frovatriptan—Hypersensitivity—Pregabalin—epilepsy syndrome	7.42e-05	0.000165	CcSEcCtD
Frovatriptan—Anorexia—Topiramate—epilepsy syndrome	7.4e-05	0.000164	CcSEcCtD
Frovatriptan—Dizziness—Valproic Acid—epilepsy syndrome	7.36e-05	0.000163	CcSEcCtD
Frovatriptan—Body temperature increased—Gabapentin—epilepsy syndrome	7.3e-05	0.000162	CcSEcCtD
Frovatriptan—Abdominal pain—Gabapentin—epilepsy syndrome	7.3e-05	0.000162	CcSEcCtD
Frovatriptan—Asthenia—Pregabalin—epilepsy syndrome	7.22e-05	0.00016	CcSEcCtD
Frovatriptan—Pruritus—Pregabalin—epilepsy syndrome	7.12e-05	0.000158	CcSEcCtD
Frovatriptan—Vomiting—Valproic Acid—epilepsy syndrome	7.08e-05	0.000157	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	7.08e-05	0.000157	CcSEcCtD
Frovatriptan—Insomnia—Topiramate—epilepsy syndrome	7.02e-05	0.000156	CcSEcCtD
Frovatriptan—Headache—Valproic Acid—epilepsy syndrome	6.98e-05	0.000155	CcSEcCtD
Frovatriptan—Paraesthesia—Topiramate—epilepsy syndrome	6.97e-05	0.000155	CcSEcCtD
Frovatriptan—Dyspnoea—Topiramate—epilepsy syndrome	6.92e-05	0.000154	CcSEcCtD
Frovatriptan—Somnolence—Topiramate—epilepsy syndrome	6.9e-05	0.000153	CcSEcCtD
Frovatriptan—Diarrhoea—Pregabalin—epilepsy syndrome	6.89e-05	0.000153	CcSEcCtD
Frovatriptan—Dyspepsia—Topiramate—epilepsy syndrome	6.84e-05	0.000152	CcSEcCtD
Frovatriptan—Hypersensitivity—Gabapentin—epilepsy syndrome	6.8e-05	0.000151	CcSEcCtD
Frovatriptan—Decreased appetite—Topiramate—epilepsy syndrome	6.75e-05	0.00015	CcSEcCtD
Frovatriptan—Fatigue—Topiramate—epilepsy syndrome	6.7e-05	0.000149	CcSEcCtD
Frovatriptan—Dizziness—Pregabalin—epilepsy syndrome	6.66e-05	0.000148	CcSEcCtD
Frovatriptan—Constipation—Topiramate—epilepsy syndrome	6.64e-05	0.000147	CcSEcCtD
Frovatriptan—Pain—Topiramate—epilepsy syndrome	6.64e-05	0.000147	CcSEcCtD
Frovatriptan—Asthenia—Gabapentin—epilepsy syndrome	6.62e-05	0.000147	CcSEcCtD
Frovatriptan—Nausea—Valproic Acid—epilepsy syndrome	6.61e-05	0.000147	CcSEcCtD
Frovatriptan—Pruritus—Gabapentin—epilepsy syndrome	6.53e-05	0.000145	CcSEcCtD
Frovatriptan—Vomiting—Pregabalin—epilepsy syndrome	6.4e-05	0.000142	CcSEcCtD
Frovatriptan—Feeling abnormal—Topiramate—epilepsy syndrome	6.4e-05	0.000142	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Topiramate—epilepsy syndrome	6.35e-05	0.000141	CcSEcCtD
Frovatriptan—Diarrhoea—Gabapentin—epilepsy syndrome	6.32e-05	0.00014	CcSEcCtD
Frovatriptan—Headache—Pregabalin—epilepsy syndrome	6.31e-05	0.00014	CcSEcCtD
Frovatriptan—Abdominal pain—Topiramate—epilepsy syndrome	6.14e-05	0.000136	CcSEcCtD
Frovatriptan—Body temperature increased—Topiramate—epilepsy syndrome	6.14e-05	0.000136	CcSEcCtD
Frovatriptan—Dizziness—Gabapentin—epilepsy syndrome	6.1e-05	0.000135	CcSEcCtD
Frovatriptan—Nausea—Pregabalin—epilepsy syndrome	5.98e-05	0.000133	CcSEcCtD
Frovatriptan—Vomiting—Gabapentin—epilepsy syndrome	5.87e-05	0.00013	CcSEcCtD
Frovatriptan—Headache—Gabapentin—epilepsy syndrome	5.78e-05	0.000128	CcSEcCtD
Frovatriptan—Hypersensitivity—Topiramate—epilepsy syndrome	5.72e-05	0.000127	CcSEcCtD
Frovatriptan—Asthenia—Topiramate—epilepsy syndrome	5.57e-05	0.000124	CcSEcCtD
Frovatriptan—Pruritus—Topiramate—epilepsy syndrome	5.49e-05	0.000122	CcSEcCtD
Frovatriptan—Nausea—Gabapentin—epilepsy syndrome	5.48e-05	0.000122	CcSEcCtD
Frovatriptan—Diarrhoea—Topiramate—epilepsy syndrome	5.31e-05	0.000118	CcSEcCtD
Frovatriptan—Dizziness—Topiramate—epilepsy syndrome	5.14e-05	0.000114	CcSEcCtD
Frovatriptan—Vomiting—Topiramate—epilepsy syndrome	4.94e-05	0.00011	CcSEcCtD
Frovatriptan—Headache—Topiramate—epilepsy syndrome	4.87e-05	0.000108	CcSEcCtD
Frovatriptan—Nausea—Topiramate—epilepsy syndrome	4.61e-05	0.000102	CcSEcCtD
Frovatriptan—HTR1B—Signaling Pathways—OXT—epilepsy syndrome	3.03e-05	0.0002	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CXCL2—epilepsy syndrome	3.03e-05	0.0002	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CHRM3—epilepsy syndrome	3.01e-05	0.000199	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CASP2—epilepsy syndrome	3.01e-05	0.000199	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—GRM5—epilepsy syndrome	3.01e-05	0.000199	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—COX3—epilepsy syndrome	3.01e-05	0.000199	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CCR5—epilepsy syndrome	2.99e-05	0.000197	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—HTR2A—epilepsy syndrome	2.99e-05	0.000197	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—AVP—epilepsy syndrome	2.95e-05	0.000195	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—HTR2A—epilepsy syndrome	2.93e-05	0.000193	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CX3CR1—epilepsy syndrome	2.89e-05	0.000191	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—PRKCB—epilepsy syndrome	2.89e-05	0.00019	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TSC1—epilepsy syndrome	2.88e-05	0.00019	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PTK2B—epilepsy syndrome	2.88e-05	0.00019	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CACNA2D2—epilepsy syndrome	2.85e-05	0.000188	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SLCO1A2—epilepsy syndrome	2.85e-05	0.000188	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PFKL—epilepsy syndrome	2.85e-05	0.000188	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—KCNB1—epilepsy syndrome	2.85e-05	0.000188	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SLC6A8—epilepsy syndrome	2.85e-05	0.000188	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—AGT—epilepsy syndrome	2.84e-05	0.000187	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CHRM2—epilepsy syndrome	2.83e-05	0.000187	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—BDKRB1—epilepsy syndrome	2.83e-05	0.000187	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CX3CL1—epilepsy syndrome	2.83e-05	0.000187	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—PRKCB—epilepsy syndrome	2.83e-05	0.000186	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PTK2B—epilepsy syndrome	2.82e-05	0.000186	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TSC1—epilepsy syndrome	2.82e-05	0.000186	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NTRK2—epilepsy syndrome	2.8e-05	0.000185	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CCR2—epilepsy syndrome	2.8e-05	0.000185	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—SST—epilepsy syndrome	2.8e-05	0.000185	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	2.79e-05	0.000184	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—AGT—epilepsy syndrome	2.78e-05	0.000183	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—DUSP6—epilepsy syndrome	2.78e-05	0.000183	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	2.77e-05	0.000183	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CDC42—epilepsy syndrome	2.77e-05	0.000183	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—GABBR1—epilepsy syndrome	2.76e-05	0.000182	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CCR2—epilepsy syndrome	2.74e-05	0.000181	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—SST—epilepsy syndrome	2.74e-05	0.000181	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NTRK2—epilepsy syndrome	2.74e-05	0.000181	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—ADRA2A—epilepsy syndrome	2.74e-05	0.000181	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PLAT—epilepsy syndrome	2.73e-05	0.00018	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—DUSP6—epilepsy syndrome	2.72e-05	0.000179	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—ADRA2A—epilepsy syndrome	2.68e-05	0.000177	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—AVP—epilepsy syndrome	2.68e-05	0.000177	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PLAT—epilepsy syndrome	2.67e-05	0.000176	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HRH3—epilepsy syndrome	2.64e-05	0.000174	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CXCL12—epilepsy syndrome	2.63e-05	0.000174	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—BDKRB2—epilepsy syndrome	2.63e-05	0.000174	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—POMC—epilepsy syndrome	2.63e-05	0.000173	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—PRKCB—epilepsy syndrome	2.62e-05	0.000173	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—IL6ST—epilepsy syndrome	2.61e-05	0.000172	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—NEU1—epilepsy syndrome	2.61e-05	0.000172	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—UPB1—epilepsy syndrome	2.61e-05	0.000172	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ATIC—epilepsy syndrome	2.61e-05	0.000172	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—OPRM1—epilepsy syndrome	2.6e-05	0.000172	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—JUNB—epilepsy syndrome	2.58e-05	0.00017	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CNR1—epilepsy syndrome	2.58e-05	0.00017	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CXCL12—epilepsy syndrome	2.58e-05	0.00017	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—BDKRB2—epilepsy syndrome	2.58e-05	0.00017	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PLCB1—epilepsy syndrome	2.57e-05	0.00017	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—POMC—epilepsy syndrome	2.57e-05	0.00017	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—PRKCB—epilepsy syndrome	2.57e-05	0.000169	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—IL6ST—epilepsy syndrome	2.56e-05	0.000169	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—JUNB—epilepsy syndrome	2.53e-05	0.000167	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CNR1—epilepsy syndrome	2.53e-05	0.000167	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PLCB1—epilepsy syndrome	2.52e-05	0.000166	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HTR7—epilepsy syndrome	2.52e-05	0.000166	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HSD17B4—epilepsy syndrome	2.51e-05	0.000166	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—CCR5—epilepsy syndrome	2.51e-05	0.000165	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HTR7—epilepsy syndrome	2.47e-05	0.000163	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCR3—epilepsy syndrome	2.46e-05	0.000162	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—HTR2A—epilepsy syndrome	2.46e-05	0.000162	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HBEGF—epilepsy syndrome	2.45e-05	0.000161	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	2.43e-05	0.00016	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GBE1—epilepsy syndrome	2.43e-05	0.00016	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—AKT3—epilepsy syndrome	2.4e-05	0.000158	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HBEGF—epilepsy syndrome	2.4e-05	0.000158	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NPY—epilepsy syndrome	2.39e-05	0.000158	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ATP2A2—epilepsy syndrome	2.39e-05	0.000158	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—POMC—epilepsy syndrome	2.39e-05	0.000157	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	2.37e-05	0.000156	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—AKT3—epilepsy syndrome	2.35e-05	0.000155	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—ADAM10—epilepsy syndrome	2.35e-05	0.000155	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—POMC—epilepsy syndrome	2.34e-05	0.000154	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—CCL2—epilepsy syndrome	2.34e-05	0.000154	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—AGT—epilepsy syndrome	2.33e-05	0.000154	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HSPB1—epilepsy syndrome	2.31e-05	0.000152	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCL3—epilepsy syndrome	2.31e-05	0.000152	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CXCL2—epilepsy syndrome	2.31e-05	0.000152	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CRH—epilepsy syndrome	2.31e-05	0.000152	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—OXT—epilepsy syndrome	2.31e-05	0.000152	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—ADAM10—epilepsy syndrome	2.3e-05	0.000152	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CCL2—epilepsy syndrome	2.29e-05	0.000151	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	2.28e-05	0.00015	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CCR5—epilepsy syndrome	2.28e-05	0.00015	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—HTR2A—epilepsy syndrome	2.23e-05	0.000147	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	2.22e-05	0.000146	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—S100B—epilepsy syndrome	2.22e-05	0.000146	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—SOCS3—epilepsy syndrome	2.2e-05	0.000145	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CDC42—epilepsy syndrome	2.19e-05	0.000145	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—S100B—epilepsy syndrome	2.17e-05	0.000143	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—NT5E—epilepsy syndrome	2.16e-05	0.000143	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ALAD—epilepsy syndrome	2.16e-05	0.000143	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—PRKCB—epilepsy syndrome	2.15e-05	0.000142	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—SOCS3—epilepsy syndrome	2.15e-05	0.000142	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TSC1—epilepsy syndrome	2.15e-05	0.000142	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PTK2B—epilepsy syndrome	2.15e-05	0.000142	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CDC42—epilepsy syndrome	2.15e-05	0.000142	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—AVP—epilepsy syndrome	2.12e-05	0.00014	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—AGT—epilepsy syndrome	2.12e-05	0.00014	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—SST—epilepsy syndrome	2.09e-05	0.000138	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCR2—epilepsy syndrome	2.09e-05	0.000138	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NTRK2—epilepsy syndrome	2.09e-05	0.000138	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—AVP—epilepsy syndrome	2.08e-05	0.000137	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—DUSP6—epilepsy syndrome	2.07e-05	0.000137	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	2.06e-05	0.000136	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	2.06e-05	0.000136	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ADRA2A—epilepsy syndrome	2.04e-05	0.000135	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PLAT—epilepsy syndrome	2.04e-05	0.000134	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	2.02e-05	0.000133	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HES1—epilepsy syndrome	2.01e-05	0.000132	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ADSL—epilepsy syndrome	1.98e-05	0.00013	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HES1—epilepsy syndrome	1.96e-05	0.00013	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CXCL12—epilepsy syndrome	1.96e-05	0.00013	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—BDKRB2—epilepsy syndrome	1.96e-05	0.00013	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—POMC—epilepsy syndrome	1.96e-05	0.000129	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PRKCB—epilepsy syndrome	1.95e-05	0.000129	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—FYN—epilepsy syndrome	1.95e-05	0.000129	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—IL6ST—epilepsy syndrome	1.95e-05	0.000128	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—H2AFX—epilepsy syndrome	1.94e-05	0.000128	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MEF2C—epilepsy syndrome	1.94e-05	0.000128	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GLUL—epilepsy syndrome	1.94e-05	0.000128	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—JUNB—epilepsy syndrome	1.93e-05	0.000127	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CNR1—epilepsy syndrome	1.93e-05	0.000127	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PLCB1—epilepsy syndrome	1.92e-05	0.000127	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—FYN—epilepsy syndrome	1.91e-05	0.000126	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	1.9e-05	0.000126	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—H2AFX—epilepsy syndrome	1.9e-05	0.000126	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MEF2C—epilepsy syndrome	1.9e-05	0.000125	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HTR7—epilepsy syndrome	1.88e-05	0.000124	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—YWHAZ—epilepsy syndrome	1.88e-05	0.000124	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NGF—epilepsy syndrome	1.85e-05	0.000122	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—YWHAZ—epilepsy syndrome	1.84e-05	0.000121	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HBEGF—epilepsy syndrome	1.83e-05	0.00012	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NGF—epilepsy syndrome	1.82e-05	0.00012	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CCR5—epilepsy syndrome	1.8e-05	0.000119	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—AKT3—epilepsy syndrome	1.79e-05	0.000118	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	1.78e-05	0.000117	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—POMC—epilepsy syndrome	1.78e-05	0.000117	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CCR5—epilepsy syndrome	1.77e-05	0.000117	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HTR2A—epilepsy syndrome	1.77e-05	0.000116	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ADAM10—epilepsy syndrome	1.75e-05	0.000115	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CCL2—epilepsy syndrome	1.74e-05	0.000115	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HTR2A—epilepsy syndrome	1.73e-05	0.000114	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—AQP1—epilepsy syndrome	1.73e-05	0.000114	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TSC2—epilepsy syndrome	1.68e-05	0.000111	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—AGT—epilepsy syndrome	1.68e-05	0.00011	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.66e-05	0.00011	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—S100B—epilepsy syndrome	1.66e-05	0.000109	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TSC2—epilepsy syndrome	1.64e-05	0.000108	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—APOE—epilepsy syndrome	1.64e-05	0.000108	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—AGT—epilepsy syndrome	1.64e-05	0.000108	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—SOCS3—epilepsy syndrome	1.64e-05	0.000108	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CDC42—epilepsy syndrome	1.64e-05	0.000108	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—KDR—epilepsy syndrome	1.61e-05	0.000106	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—APOE—epilepsy syndrome	1.61e-05	0.000106	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—AVP—epilepsy syndrome	1.58e-05	0.000104	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—KDR—epilepsy syndrome	1.57e-05	0.000104	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	1.56e-05	0.000103	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	1.56e-05	0.000103	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PRKCB—epilepsy syndrome	1.55e-05	0.000102	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IL6ST—epilepsy syndrome	1.54e-05	0.000102	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PRKCB—epilepsy syndrome	1.52e-05	0.0001	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IL6ST—epilepsy syndrome	1.51e-05	9.96e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HES1—epilepsy syndrome	1.5e-05	9.87e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.46e-05	9.6e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—FYN—epilepsy syndrome	1.46e-05	9.6e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—H2AFX—epilepsy syndrome	1.45e-05	9.57e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MEF2C—epilepsy syndrome	1.45e-05	9.55e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.43e-05	9.41e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—POMC—epilepsy syndrome	1.41e-05	9.3e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—YWHAZ—epilepsy syndrome	1.4e-05	9.23e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NGF—epilepsy syndrome	1.38e-05	9.13e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—POMC—epilepsy syndrome	1.38e-05	9.11e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CCL2—epilepsy syndrome	1.38e-05	9.1e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CCL2—epilepsy syndrome	1.35e-05	8.91e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCR5—epilepsy syndrome	1.35e-05	8.88e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HTR2A—epilepsy syndrome	1.32e-05	8.69e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	1.27e-05	8.41e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TSC2—epilepsy syndrome	1.25e-05	8.25e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—AGT—epilepsy syndrome	1.25e-05	8.24e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—FGF2—epilepsy syndrome	1.25e-05	8.22e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	1.24e-05	8.19e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	1.23e-05	8.14e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.23e-05	8.08e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—APOE—epilepsy syndrome	1.22e-05	8.08e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—FGF2—epilepsy syndrome	1.22e-05	8.05e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—KDR—epilepsy syndrome	1.2e-05	7.91e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—RELA—epilepsy syndrome	1.16e-05	7.63e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PRKCB—epilepsy syndrome	1.15e-05	7.62e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IL6ST—epilepsy syndrome	1.15e-05	7.59e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MTOR—epilepsy syndrome	1.14e-05	7.49e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—RELA—epilepsy syndrome	1.13e-05	7.48e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.12e-05	7.37e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	1.11e-05	7.35e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MTOR—epilepsy syndrome	1.11e-05	7.33e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	1.06e-05	6.99e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—BCHE—epilepsy syndrome	1.06e-05	6.97e-05	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—AKT1—epilepsy syndrome	1.05e-05	6.95e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—POMC—epilepsy syndrome	1.05e-05	6.94e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CASP3—epilepsy syndrome	1.04e-05	6.89e-05	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—AKT1—epilepsy syndrome	1.03e-05	6.81e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCL2—epilepsy syndrome	1.03e-05	6.79e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CASP3—epilepsy syndrome	1.02e-05	6.74e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—JUN—epilepsy syndrome	1.01e-05	6.69e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	1.01e-05	6.64e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	9.97e-06	6.57e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—JUN—epilepsy syndrome	9.93e-06	6.55e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—TH—epilepsy syndrome	9.93e-06	6.55e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MMP9—epilepsy syndrome	9.87e-06	6.51e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	9.78e-06	6.45e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MMP9—epilepsy syndrome	9.66e-06	6.37e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—AKT1—epilepsy syndrome	9.57e-06	6.31e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—AKT1—epilepsy syndrome	9.37e-06	6.18e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	9.3e-06	6.13e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—SRC—epilepsy syndrome	9.1e-06	6e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—SRC—epilepsy syndrome	8.91e-06	5.87e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—VEGFA—epilepsy syndrome	8.86e-06	5.84e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—VEGFA—epilepsy syndrome	8.68e-06	5.72e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	8.63e-06	5.69e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	8.47e-06	5.58e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	8.29e-06	5.47e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CAT—epilepsy syndrome	8.18e-06	5.39e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	7.95e-06	5.25e-05	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	7.86e-06	5.18e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	7.79e-06	5.14e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	7.56e-06	4.99e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GPX1—epilepsy syndrome	7.4e-06	4.88e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	7.36e-06	4.85e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	7.14e-06	4.71e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	6.79e-06	4.48e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	6.61e-06	4.36e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—AGT—epilepsy syndrome	6.48e-06	4.28e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—APOE—epilepsy syndrome	6.35e-06	4.19e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—AKT1—epilepsy syndrome	5.65e-06	3.73e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—AKT1—epilepsy syndrome	5.54e-06	3.65e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—POMC—epilepsy syndrome	5.46e-06	3.6e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ALB—epilepsy syndrome	4.98e-06	3.28e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	4.35e-06	2.87e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	4.22e-06	2.78e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—AKT1—epilepsy syndrome	2.19e-06	1.44e-05	CbGpPWpGaD
